Shinpoong PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Shinpoong PharmaceuticalLtd has a total shareholder equity of ₩270.8B and total debt of ₩45.0B, which brings its debt-to-equity ratio to 16.6%. Its total assets and total liabilities are ₩350.1B and ₩79.3B respectively.
Key information
16.6%
Debt to equity ratio
₩45.00b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩60.58b |
| Equity | ₩270.78b |
| Total liabilities | ₩79.30b |
| Total assets | ₩350.08b |
Recent financial health updates
Recent updates
Shinpoong Pharmaceutical Co.,Ltd (KRX:019170) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 24
Do Shin Poong Pharm.Co.Ltd's (KRX:019170) Earnings Warrant Your Attention?
Mar 07Declining Stock and Decent Financials: Is The Market Wrong About Shin Poong Pharm.Co.,Ltd. (KRX:019170)?
Feb 01
We Wouldn't Rely On Shin Poong Pharm.Co.Ltd's (KRX:019170) Statutory Earnings As A Guide
Jan 05Is Shin Poong Pharm.Co.Ltd (KRX:019170) Using Too Much Debt?
Dec 10Financial Position Analysis
Short Term Liabilities: A019170's short term assets (₩198.9B) exceed its short term liabilities (₩76.4B).
Long Term Liabilities: A019170's short term assets (₩198.9B) exceed its long term liabilities (₩2.9B).
Debt to Equity History and Analysis
Debt Level: A019170 has more cash than its total debt.
Reducing Debt: A019170's debt to equity ratio has reduced from 50.4% to 16.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A019170 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A019170 has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 49.5% each year.